|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.989
|
Mouse |
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.967
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.961
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.933
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.928
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.852
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.852
|
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.850
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.804
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.787
|
|
|
|
peptidyl lysine trimethylation
|
GO:0018023 |
12 |
0.781
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.737
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.722
|
|
|
|
sertoli cell differentiation
|
GO:0060008 |
18 |
0.605
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.576
|
Mouse |
|
|
histone h4 k20 trimethylation
|
GO:0034773 |
2 |
0.528
|
|
|
|
sertoli cell development
|
GO:0060009 |
15 |
0.477
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.392
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.379
|
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.274
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.225
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.198
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.189
|
Mouse |
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.184
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.181
|
Mouse |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.180
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.176
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.170
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.153
|
Mouse |
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.151
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.139
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.138
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.137
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.128
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.128
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.127
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.117
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.117
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.115
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.114
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.113
|
|
|
|
negative regulation of dendrite development
|
GO:2000171 |
9 |
0.111
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.111
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.110
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.109
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.102
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.098
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.088
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.087
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.085
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.080
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.079
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.078
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.078
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.076
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.076
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.074
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.073
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.071
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.071
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.070
|
Mouse |
|
|
gene silencing
|
GO:0016458 |
38 |
0.068
|
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.068
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.067
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.066
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.065
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.065
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.062
|
|
|
|
demethylation
|
GO:0070988 |
23 |
0.062
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.058
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.056
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.056
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.056
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.056
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.056
|
|
|
|
dna dealkylation
|
GO:0035510 |
11 |
0.055
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.053
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.053
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.053
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.052
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.052
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.052
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.051
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.049
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.049
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.049
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.046
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.046
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.046
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.046
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.046
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.045
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.045
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.044
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.044
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.043
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.043
|
|
|
|
axon target recognition
|
GO:0007412 |
4 |
0.043
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.043
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.042
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.042
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.042
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.042
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.042
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.041
|
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.041
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.041
|
|
|
|
dna replication independent nucleosome assembly
|
GO:0006336 |
1 |
0.041
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.040
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.040
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.040
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.039
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.039
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.038
|
|
|
|
maintenance of apical basal cell polarity
|
GO:0035090 |
3 |
0.038
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.037
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.037
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.037
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.037
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.036
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.036
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.035
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.035
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.035
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.034
|
|
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.034
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.034
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.033
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.032
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.032
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.032
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.032
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.032
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.032
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.031
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.031
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.031
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.031
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.030
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.030
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.030
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.030
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.030
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.029
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.029
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.029
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.029
|
|
|
|
regulation of gene expression by genetic imprinting
|
GO:0006349 |
15 |
0.029
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.029
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.028
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.028
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.028
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.028
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.028
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.027
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.027
|
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.027
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.027
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.027
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.026
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.026
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.026
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.026
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.026
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.026
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.026
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.025
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.025
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.025
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.024
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.024
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.024
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.024
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.024
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.024
|
|
|
|
phosphatidylinositol phosphorylation
|
GO:0046854 |
23 |
0.023
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.023
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.023
|
|
|
|
protein o linked glycosylation
|
GO:0006493 |
16 |
0.023
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.023
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.023
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.023
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.023
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.023
|
|
|
|
reciprocal dna recombination
|
GO:0035825 |
16 |
0.023
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.022
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.022
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.022
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.022
|
|
|
|
centrosome organization
|
GO:0051297 |
26 |
0.022
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.022
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.022
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.021
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.021
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.021
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.021
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.021
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.021
|
|
|
|
positive regulation of ubiquitin protein transferase activity
|
GO:0051443 |
4 |
0.021
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.021
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.021
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.021
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.021
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
31 |
0.020
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.020
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.020
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.020
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.020
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.020
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.020
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.020
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.020
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.020
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.020
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.019
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.019
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.019
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.019
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.019
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.019
|
|
|
|
histone demethylation
|
GO:0016577 |
13 |
0.019
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.019
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.018
|
|
|
|
regulation of sister chromatid segregation
|
GO:0033045 |
13 |
0.018
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.018
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.018
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.018
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.018
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.018
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.018
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.018
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.018
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.018
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.018
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.018
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.018
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.017
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.017
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.017
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.017
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.017
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.017
|
|
|
|
lipid phosphorylation
|
GO:0046834 |
25 |
0.017
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.017
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.017
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.017
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.017
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.017
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.017
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.016
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.016
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.016
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.016
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.016
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.016
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.016
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.016
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.016
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.016
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.016
|
|
|
|
dendritic spine development
|
GO:0060996 |
30 |
0.016
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.016
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.016
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.016
|
|
|
|
maintenance of epithelial cell apical basal polarity
|
GO:0045199 |
2 |
0.015
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.015
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.015
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.015
|
|
|
|
regulation of ral gtpase activity
|
GO:0032315 |
4 |
0.015
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.015
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.015
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.015
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.015
|
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
9 |
0.015
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.015
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.015
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.015
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.015
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.015
|
|
|
|
histone lysine demethylation
|
GO:0070076 |
13 |
0.015
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.014
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.014
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.014
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.014
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.014
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.014
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.014
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.014
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.014
|
|
|
|
sister chromatid segregation
|
GO:0000819 |
20 |
0.014
|
|
|
|
protein localization to synapse
|
GO:0035418 |
11 |
0.014
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.014
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.014
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
24 |
0.014
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.014
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.014
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.014
|
|
|
|
regulation of dna recombination
|
GO:0000018 |
34 |
0.014
|
|
|
|
dna dependent dna replication maintenance of fidelity
|
GO:0045005 |
3 |
0.014
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.014
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.014
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.014
|
|
|
|
reciprocal meiotic recombination
|
GO:0007131 |
16 |
0.013
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.013
|
|
|
|
positive regulation of nuclear division
|
GO:0051785 |
27 |
0.013
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.013
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.013
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.013
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.013
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.013
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.013
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.013
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.013
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.013
|
|
|
|
positive regulation of peptidyl serine phosphorylation
|
GO:0033138 |
25 |
0.013
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.013
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.013
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.013
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.013
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.013
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.013
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.013
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.013
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.013
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.013
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.012
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.012
|
|
|
|
medulla oblongata development
|
GO:0021550 |
3 |
0.012
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.012
|
|
|
|
dna templated transcription termination
|
GO:0006353 |
4 |
0.012
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.012
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.012
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.012
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.012
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.012
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.012
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.012
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.012
|
|
|
|
regulation of mitotic sister chromatid segregation
|
GO:0033047 |
12 |
0.012
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.012
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.012
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.012
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.012
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.012
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.012
|
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.012
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.012
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.012
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.012
|
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.012
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.012
|
|
|
|
positive regulation of mitotic sister chromatid separation
|
GO:1901970 |
2 |
0.012
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.012
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.012
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.012
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.012
|
|
|
|
dna demethylation
|
GO:0080111 |
10 |
0.011
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.011
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.011
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.011
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.011
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.011
|
|
|
|
lateral mesodermal cell differentiation
|
GO:0048371 |
3 |
0.011
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.011
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.011
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.011
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.011
|
|
|
|
regulation of peptidyl threonine phosphorylation
|
GO:0010799 |
12 |
0.011
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.011
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.011
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.011
|
|
|
|
heterochromatin organization involved in chromatin silencing
|
GO:0070868 |
1 |
0.011
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.011
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.011
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.011
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.011
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.011
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.011
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.011
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.011
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.011
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.011
|
|
|
|
spindle assembly involved in meiosis
|
GO:0090306 |
4 |
0.011
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.011
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.011
|
|
|
|
positive regulation of carbohydrate metabolic process
|
GO:0045913 |
30 |
0.011
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.011
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.011
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.011
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.011
|
|
|
|
regulation of nuclear cell cycle dna replication
|
GO:0033262 |
2 |
0.011
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.011
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.011
|
|
|
|
post embryonic retina morphogenesis in camera type eye
|
GO:0060060 |
3 |
0.011
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.011
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.011
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.011
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.011
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.011
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.011
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
28 |
0.011
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.011
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.011
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.011
|
|
|
|
positive regulation of gluconeogenesis
|
GO:0045722 |
11 |
0.010
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.010
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.010
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.010
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.010
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.010
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.010
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.010
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.010
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.010
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.010
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.010
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.010
|
|
|
|
negative regulation of secondary metabolite biosynthetic process
|
GO:1900377 |
2 |
0.010
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.010
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.010
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.010
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.010
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.010
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.010
|
|
|
|
translesion synthesis
|
GO:0019985 |
1 |
0.010
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.010
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.010
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.010
|
|
|
|
negative regulation of relaxation of cardiac muscle
|
GO:1901898 |
2 |
0.010
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.010
|
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.010
|
|
|
|
positive regulation of tor signaling
|
GO:0032008 |
3 |
0.010
|
|
